Literature DB >> 22476913

Ligand binding assays in the 21st century laboratory-a call for change.

Chad A Ray, Ago B Ahene.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22476913      PMCID： PMC3385813          DOI： 10.1208/s12248-012-9351-8

Source DB:  PubMed          Journal:  AAPS J        ISSN： 1550-7416            Impact factor:   4.009


× No keyword cloud information.
  8 in total

1.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

2.  Ligand-binding assays in the 21st Century laboratory: recommendations for an automated data interchange process.

Authors:  Sheldon S Leung; Joel Usansky; Robert Lynde; Theingi Thway; Robert Hendricks; David Rusnak
Journal:  AAPS J       Date:  2012-01-14       Impact factor: 4.009

3.  Ligand binding assays in the 21st Century laboratory: automation.

Authors:  Ago B Ahene; Chris Morrow; David Rusnak; Susan Spitz; Joel Usansky; Holger Pils; Francesca Civoli; Kinnari Pandya; Brian Sue; Daniel Leach; John Derent
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

Review 4.  Ligand binding assays in the 21st century laboratory: recommendations for characterization and supply of critical reagents.

Authors:  Denise M O'Hara; Valerie Theobald; Adrienne Clements Egan; Joel Usansky; Murli Krishna; Julie TerWee; Mauricio Maia; Frank P Spriggs; John Kenney; Afshin Safavi; Jeannine Keefe
Journal:  AAPS J       Date:  2012-03-14       Impact factor: 4.009

5.  Ligand binding assays in the 21st Century laboratory: platforms.

Authors:  Franklin P Spriggs; Zhandong Don Zhong; Afshin Safavi; Darshana Jani; Narasaiah Dontha; Anita Kant; Jenny Ly; Lia Brilando; Karolina Österlund; Nathalie Rouleau; Saloumeh Kadkhodayan Fischer; Martin Boissonneault; Chad Ray
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

6.  Spending on new drug development1.

Authors:  Christopher Paul Adams; Van Vu Brantner
Journal:  Health Econ       Date:  2010-02       Impact factor: 3.046

7.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.